Effect of SAcubitril/Valsartan on left vEntricular ejection fraction and on the potential indication for Implantable Cardioverter Defibrillator in primary prevention: the SAVE-ICD study.
Guerra F, Ammendola E, Ziacchi M, Aspromonte V, Pellegrino PL, Del Giorno G, Dell'Era G, Pimpini L, Santoro F, Floris R, Stronati G, Nigro G, Paolisso P, Guido A, Maglia G, Brunetti ND, Carbone A, Gravellone M, Antonicelli R, Cannone M, Accogli M, Dello Russo A, Palmisano P.
Guerra F, et al. Among authors: guido a.
Eur J Clin Pharmacol. 2021 Dec;77(12):1835-1842. doi: 10.1007/s00228-021-03189-8. Epub 2021 Jul 19.
Eur J Clin Pharmacol. 2021.
PMID: 34279677